Eleanor Ramos
Chief Tech/Sci/R&D Officer chez PROVENTION BIO, INC.
Profil
Eleanor Leni Ramos is currently the Director at Ask About Lung Cancer, Inc. and the Chief Medical Officer at Provention Bio, Inc. Previously, she held positions such as Director-Renal Transplant Services at The Brigham & Women's Hospital, Inc. and the University of Florida, Director-Clinical Research at Roche Global Development, and Executive Director-Clinical Trials Group at Immune Tolerance Network.
She also served as Vice President-Global Clinical Research at Bristol Myers Squibb Co. and Chief Medical Officer & Senior Vice President at ZymoGenetics, Inc. Additionally, she was the Chief Medical Officer at Theraclone Sciences, Inc. and Global Blood Therapeutics, Inc. Dr. Ramos obtained her undergraduate and doctorate degrees from Tufts University.
Postes actifs de Eleanor Ramos
| Sociétés | Poste | Début |
|---|---|---|
| PROVENTION BIO, INC. | Chief Tech/Sci/R&D Officer | 01/06/2017 |
Ask About Lung Cancer, Inc.
 Ask About Lung Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Ask About Lung Cancer, Inc. operates as a voluntary health organization that focuses on lung cancer patients. The non-profit company is based in Concord, MA. | Director/Board Member | - |
Anciens postes connus de Eleanor Ramos
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBAL BLOOD THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 24/10/2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/12/2006 |
| University of Florida | Corporate Officer/Principal | - |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
| Roche Global Development | Corporate Officer/Principal | - |
Formation de Eleanor Ramos
| Tufts University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 8 |
|---|---|
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Commercial Services |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
| Roche Global Development | |
Immune Tolerance Network
 Immune Tolerance Network Miscellaneous Commercial ServicesCommercial Services Immune Tolerance Network provides clinical research services. It offers immune tolerance therapies for autoimmune disease, allergies and asthma, organ transplantation, and type 1 diabetes. The company was founded by Jeffrey A. Bluestone in 1999 and is headquartered in Seattle, WA. | Commercial Services |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
Ask About Lung Cancer, Inc.
Ask About Lung Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Ask About Lung Cancer, Inc. operates as a voluntary health organization that focuses on lung cancer patients. The non-profit company is based in Concord, MA. | Commercial Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
